INCREASED TREATMENT SATISFACTION WITH CGM IN PEOPLE WITH T1D IN THE GOLD TRIAL IS MAINLY DUE TO PERCEIVED IMPROVEMENTS IN CONVENIENCE AND FLEXIBILITY
Other text in scientific journal, 2023
Author
D. Pylov
University of Gothenburg
Henrik Imberg
Chalmers, Mathematical Sciences, Applied Mathematics and Statistics
W. Polonsky
University of California at San Diego (UCSD)
J. Hellman
Uppsala University
E. Schwarcz
Örebro University
T. Heise
Profil
T. Nystrom
Karolinska Institutet
I. Hirsch
University of Washington
J. Bolinder
Karolinska Institutet
M. Lind
University of Gothenburg
Diabetes Technology and Therapeutics
1520-9156 (ISSN)
Vol. 25 Suppl 2 A222-A223 Meeting Abstract145Subject Categories
Endocrinology and Diabetes